A request from the National Down Syndrome Society, who asks that we write an email to Sequnom the makers of MaterniT21 the new prenatal screening test which we fear may decimate the Down syndrome population of 400,000 in the US.
Read about it in my article.
Jon Coleman the Director of NDSS says,
Please urge Sequenom to meet all NDSS criteria for prenatal test companies. To see the NDSS Criteria to Evaluate Companies with Non-Invasive Prenatal Diagnostic Tests for Down Syndrome click here.